Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely biochemical or toxicology studies will not be published. Papers describing the behavioral effects of novel drugs in models of psychiatric, neurological and cognitive disorders, and central pain must include a positive control unless the paper is on a disease where such a drug is not available yet. Papers focusing on physiological processes (e.g., peripheral pain mechanisms, body temperature regulation, seizure activity) are not accepted as we would like to retain the focus of Pharmacology Biochemistry & Behavior on behavior and its interaction with the biochemistry and neurochemistry of the central nervous system. Papers describing the effects of plant materials are generally not considered, unless the active ingredients are studied, the extraction method is well described, the doses tested are known, and clear and definite experimental evidence on the mechanism of action of the active ingredients is provided.

《药理学生物化学与行为》发表药理学和生物化学领域的原创报告，主要侧重点和理论背景是行为。投稿可能涉及临床、临床前或基础研究。纯生物化学或毒理学研究将不予发表。描述新型药物在精神、神经和认知障碍以及中枢疼痛模型中的行为影响的论文必须包括阳性对照，除非该论文研究的疾病尚无此类药物。我们不接受关注生理过程（例如外周疼痛机制、体温调节、癫痫发作）的论文，因为我们希望将《药理学生物化学与行为》的重点放在行为及其与中枢神经系统的生物化学和神经化学的相互作用上。描述植物材料影响的论文通常不予考虑，除非研究了活性成分、很好地描述了提取方法、已知测试剂量并提供了关于活性成分作用机制的明确实验证据。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-行为科学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为3.3，平均审稿速度为 一般,3-6周 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。